| 1 |
35563343 | Local Insulin-Derived Amyloidosis Model Confronted with Silymarin: Histological Insights and Gene Expression of MMP, TNF-α, and IL-6. | 2022 Apr 29 |
2 |
| 2 |
32950646 | Silymarin is an ally against insulin resistance: A review. | 2021 Jul-Aug |
4 |
| 3 |
33019400 | The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis. | 2020 Oct 2 |
1 |
| 4 |
29895491 | Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial. | 2018 May 15 |
3 |
| 5 |
30477860 | The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. | 2018 Dec |
1 |
| 6 |
21466434 | Silymarin in the prevention and treatment of liver diseases and primary liver cancer. | 2012 Jan |
1 |
| 7 |
19073452 | [Silymarin in the treatment of chronic liver diseases: past and future]. | 2008 Dec 21 |
1 |
| 8 |
9126802 | Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. | 1997 Apr |
5 |